Alpha 2.0
Login Register
» Authors » Jason Zimmerman

Jason Zimmerman

Explore the profile of Jason Zimmerman including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 12
Citations 128
Followers 0
Related Specialties
General Medicine
Biology
Microbiology
Top 10 Co-Authors
Israel Zyskind
Avi Z Rosenberg
Jonathan I Silverberg
Aristo Vojdani
Howard Amital
Gilad Halpert
Yuri Ostrinski
Yehuda Shoenfeld
Alexandre H C Marques
Hans D Ochs
Published In
Cureus
J Miss State Med Assoc
JAMA Netw Open
PLoS One
Diagnostics (Basel)
Affiliations
Soon will be listed here.
Recent Articles
1.
Evaluating the Quality and Readability of Information Provided by Generative Artificial Intelligence Chatbots on Clavicle Fracture Treatment Options
Giammanco P, Collins C, Zimmerman J, Kricfalusi M, Rice R, Trumbo M, et al.
Cureus . 2025 Feb; 17(1):e77200. PMID: 39925539
Introduction Generative artificial intelligence (AI) chatbots, like ChatGPT, have become more competent and prevalent, making their role in patient education more salient. This study aimed to compare the educational utility...
2.
Dysregulated autoantibodies targeting AGTR1 are associated with the accumulation of COVID-19 symptoms
Fonseca D, Japel M, Gyamfi M, Filgueiras I, Baiochi G, Ostrinski Y, et al.
NPJ Syst Biol Appl . 2025 Jan; 11(1):7. PMID: 39805853
Coronavirus disease 2019 (COVID-19) presents a wide spectrum of symptoms, the causes of which remain poorly understood. This study explored the associations between autoantibodies (AABs), particularly those targeting G protein-coupled...
3.
ChatGPT4's diagnostic accuracy in inpatient neurology: A retrospective cohort study
Cano-Besquet S, Rice-Canetto T, Abou-El-Hassan H, Alarcon S, Zimmerman J, Issagholian L, et al.
Heliyon . 2025 Jan; 10(24):e40964. PMID: 39759322
Background: Large language models (LLMs) such as ChatGPT-4 (CG4) are proving to be valuable tools in the medical field, not only in facilitating administrative tasks, but in augmenting medical decision-making....
4.
Severe COVID-19 patients exhibit elevated levels of autoantibodies targeting cardiolipin and platelet glycoprotein with age: a systems biology approach
Fonseca D, Filgueiras I, Marques A, Vojdani E, Halpert G, Ostrinski Y, et al.
NPJ Aging . 2023 Aug; 9(1):21. PMID: 37620330
Age is a significant risk factor for the coronavirus disease 2019 (COVID-19) severity due to immunosenescence and certain age-dependent medical conditions (e.g., obesity, cardiovascular disorder, and chronic respiratory disease). However,...
5.
Dysregulated Levels of Circulating Autoantibodies against Neuronal and Nervous System Autoantigens in COVID-19 Patients
Lavi Y, Vojdani A, Halpert G, Sharif K, Ostrinski Y, Zyskind I, et al.
Diagnostics (Basel) . 2023 Feb; 13(4). PMID: 36832180
Background: COVID-19 is a heterogenous disease resulting in long-term sequela in predisposed individuals. It is not uncommon that recovering patients endure non-respiratory ill-defined manifestations, including anosmia, and neurological and cognitive...
6.
SARS-CoV-2 Infection in Winter 2021/2022: The Association of Varying Clinical Manifestations With and Without Prior Vaccination
Jacobs M, Karp A, Alessandro C, Ganz M, Glatt A, Rosenberg A, et al.
Cureus . 2023 Feb; 14(12):e33190. PMID: 36733791
Importance SARS-CoV-2 is a rapidly evolving virus with many strains. Although vaccines have proven to be effective against earlier strains of the virus, the efficacy of vaccination status against later...
7.
Cross-sectional analysis reveals autoantibody signatures associated with COVID-19 severity
Baiocchi G, Vojdani A, Rosenberg A, Vojdani E, Halpert G, Ostrinski Y, et al.
J Med Virol . 2023 Feb; 95(2):e28538. PMID: 36722456
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is associated with increased levels of autoantibodies targeting immunological proteins such as cytokines and chemokines. Reports further indicate that COVID-19 patients...
8.
Predictors of chronic COVID-19 symptoms in a community-based cohort of adults
Silverberg J, Zyskind I, Naiditch H, Zimmerman J, Glatt A, Pinter A, et al.
PLoS One . 2022 Aug; 17(8):e0271310. PMID: 35925904
Background: COVID-19 can cause some individuals to experience chronic symptoms. Rates and predictors of chronic COVID-19 symptoms are not fully elucidated. Objective: To examine occurrence and patterns of post-acute sequelae...
9.
Autoantibodies targeting GPCRs and RAS-related molecules associate with COVID-19 severity
Cabral-Marques O, Halpert G, Schimke L, Ostrinski Y, Vojdani A, Baiocchi G, et al.
Nat Commun . 2022 Mar; 13(1):1220. PMID: 35264564
COVID-19 shares the feature of autoantibody production with systemic autoimmune diseases. In order to understand the role of these immune globulins in the pathogenesis of the disease, it is important...
10.
Association of Varying Clinical Manifestations and Positive Anti-SARS-CoV-2 IgG Antibodies: A Cross-Sectional Observational Study
Silverberg J, Zyskind I, Naiditch H, Zimmerman J, Glatt A, Pinter A, et al.
J Allergy Clin Immunol Pract . 2021 Jul; 9(9):3331-3338.e2. PMID: 34273581
Background: The complex relationship between clinical manifestations of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and individual immune responses is not fully elucidated. Objective: To examine phenotypes of symptomatology and...